Nkarta (NKTX) Other Non-Current Assets (2019 - 2026)

Nkarta's quarterly Other Non-Current Assets came in at $2.7 million in Q1 2026, little changed year-on-year from $2.7 million in Q1 2025, and up 61.64% quarter-over-quarter from $1.7 million in Q4 2025.

Nkarta has reported Other Non-Current Assets for 8 years, with the latest figure at $2.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (changed 0.0% YoY), and the FY2025 full-year result was $1.7 million, down 38.13% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $2.7 million, up from $1.7 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $3.8 million in Q4 2023, with the low at $1.7 million in Q4 2025.
  • Average Other Non-Current Assets over 5 years is $2.7 million, with a median of $2.7 million recorded in 2022.
  • Year-over-year, Other Non-Current Assets soared 407.99% in 2022 and plunged 38.13% in 2025.
  • Tracing NKTX's Other Non-Current Assets over 5 years: stood at $1.8 million in 2022, then surged by 105.19% to $3.8 million in 2023, then fell by 27.74% to $2.7 million in 2024, then sank by 38.13% to $1.7 million in 2025, then jumped by 61.64% to $2.7 million in 2026.
  • The last three Other Non-Current Assets figures came in at $2.7 million (Q1 2026), $1.7 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 60,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.26 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.13 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 63.55 Mn
10 Nkarta 232.80 Mn 232.80 Mn - 2.74 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.74 Mn
Dec 31, 2025 1.70 Mn
Sep 30, 2025 1.82 Mn
Jun 30, 2025 2.74 Mn
Mar 31, 2025 2.74 Mn
Dec 31, 2024 2.74 Mn
Sep 30, 2024 2.74 Mn
Jun 30, 2024 2.74 Mn
Mar 31, 2024 3.72 Mn
Dec 31, 2023 3.80 Mn
Sep 30, 2023 3.73 Mn
Jun 30, 2023 3.67 Mn
Mar 31, 2023 2.74 Mn
Dec 31, 2022 1.85 Mn
Sep 30, 2022 2.74 Mn
Jun 30, 2022 2.10 Mn
Mar 31, 2022 2.10 Mn
Dec 31, 2021 2.10 Mn
Sep 30, 2021 1.51 Mn
Jun 30, 2021 452,000.00
Mar 31, 2021 413,000.00
Dec 31, 2020 547,000.00
Sep 30, 2020 545,000.00
Jun 30, 2020 4.14 Mn
Dec 31, 2019 455,000.00